Nonglycemic effects of dipeptidyl peptidase-4 inhibitors

The review considers the major nonglycemic effects of dipeptidyl peptidase-4 inhibitors commonly used in diabetological practice, by using as an example sitagliptin, the first and most investigated representative of this class.

Na minha lista:
Detalhes bibliográficos
Main Authors: A S Ametov, L L Kamynina
Formato: Artigo
Idioma:Russo
Publicado em: "Consilium Medicum" Publishing house 2013-01-01
Colecção:Терапевтический архив
Assuntos:
type 2 diabetes mellitus
dipeptidyl peptidase-4 inhibitors
sitagliptin
nonglycemic effects
Acesso em linha:https://ter-arkhiv.ru/0040-3660/article/view/31226
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados